Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.

scientific article

Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/13693786.2012.682228
P698PubMed publication ID22568603
P5875ResearchGate publication ID224924599

P50authorTakahiro TakazonoQ81109209
Tomoya NishinoQ87801527
Taiga MiyazakiQ88502855
Hiroshi KakeyaQ88775740
Yoshitomo MorinagaQ90329532
Shigeru KohnoQ104013331
Yoshihiro YamamotoQ104139398
Koichi IzumikawaQ109648459
Shintaro KuriharaQ114454273
Yoshifumi ImamuraQ114454274
Katsunori YanagiharaQ114454275
Takayoshi TashiroQ114454284
Misuzu TsukamotoQ114454289
Tomo MiharaQ114454298
Akira YasuokaQ114454300
Mariko MineQ114454337
Shigeki NakamuraQ124639537
P2860cites workClinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 casesQ28264624
Underlying conditions in chronic pulmonary aspergillosis including simple aspergillomaQ28286684
Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and reviewQ34230722
Chronic forms of pulmonary aspergillosisQ34348164
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysisQ34514484
Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosisQ35636789
The invasive and saprophytic syndromes due to Aspergillus spp.Q36235153
Role of bronchoalveolar lavage diagnostics in fungal infectionsQ37449875
False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatmentQ37597610
Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluidQ37702655
Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistanceQ37786504
Chronic necrotizing pulmonary aspergillosis: approach to managementQ41574360
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in JapanQ42924895
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.Q44785839
Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcomeQ45268727
Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.Q51999514
Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma.Q53432792
Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosisQ53653935
Galactomannan in Bronchoalveolar Lavage FluidQ57559940
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectaspergillosisQ259626
bronchoalveolar lavageQ927148
P304page(s)811-817
P577publication date2012-05-09
P1433published inMedical MycologyQ6806389
P1476titleBronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis
P478volume50

Reverse relations

cites work (P2860)
Q49546197Aspergillus in airway material : Ignore or treat?
Q35142428Biomarkers for invasive aspergillosis: the challenges continue
Q60364596Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings
Q39028585Challenges in the management of chronic pulmonary aspergillosis
Q39426203Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID/ERS/ECMM and IDSA guidelines
Q47645128Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?
Q38168300Chronic pulmonary aspergillosis.
Q38120032Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis
Q40141118Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.
Q92177133Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Q58586647Evaluation of Galactomannan Testing, the -Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Q57749631Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis
Q91950206Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients
Q92457097Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis
Q58769447Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis
Q40283067Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Q55489630Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease.